Navigation Links
New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study
Date:10/6/2008

Data from SONIC Trial Showed REMICADE Therapy is More Likely to Induce

Steroid-Free Remission and Mucosal Healing Compared with Standard

Immunomodulator, Azathioprine

ORLANDO, Fla., Oct. 6 /PRNewswire/ -- Data presented for the first time from the Phase 3b Study of Patients with Crohn's Disease Naive to Immunomodulators and Biologic Therapy (SONIC) may provide new insights into the approach to care of patients with moderate to severe Crohn's disease. According to findings from the SONIC trial, a significantly greater proportion of patients with moderate to severe Crohn's disease receiving REMICADE(R) (infliximab), either in combination with azathioprine or as monotherapy, experienced steroid-free remission and mucosal healing compared with patients receiving azathioprine alone. Azathioprine is not approved by the U.S. Food and Drug Administration (FDA) for the treatment of Crohn's disease; however, it is widely used by gastroenterologists and other physicians in the United States to treat patients with Crohn's disease. Azathioprine is approved for the treatment of Crohn's disease in some countries outside the United States. Investigators reported that at week 26, 57 percent of patients receiving REMICADE combination therapy and 44 percent of patients receiving REMICADE monotherapy achieved steroid-free remission, the primary endpoint of the study, compared with 31 percent of patients receiving azathioprine alone (P < 0.001 REMICADE with azathioprine vs. azathioprine monotherapy; P = 0.009 REMICADE monotherapy vs. azathioprine monotherapy; P = 0.022 REMICADE with azathioprine vs. REMICADE monotherapy).

"Findings from the SONIC trial have the potential to challenge the treatment protocol for Crohn's disease as these data show that introducing REMICADE earlier may result in more patients achieving steroid-free remission and complete mucosal healing," said Dr. Jean-Frederic Colombel, Professor of Hepatogastroenterology
'/>"/>

SOURCE Centocor
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. More Findings on Gene Involved in Childhood Asthma
2. Interleukin Genetics to Present Important New Findings at 2008 World Congress on Osteoarthritis
3. VAI Findings Could Aid Diagnosis and Treatment of Several Types of Kidney Cancer
4. Findings on Bladder-Brain Link May Point to Better Treatments for Problems in Sleep, Attention
5. Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models
6. FDA Updates Label for AVANDIA(R) to Include Clinical Findings Demonstrating Sustained Glycemic Control for Up to Five Years
7. Tengion Scientists Publish Key Preclinical Findings Demonstrating the Benefits of Organ Regeneration Vs. Repair
8. Study Findings Show Infection Control Intervention Helps Keep Kids in School
9. Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation
10. ISTA Pharmaceuticals Announces New Phase III Clinical Findings to Support Bepreve NDA Filing
11. ACORN Presents Findings of Collaborative Metastatic Colorectal Cancer Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... 23, 2013  Haemonetics Corporation (NYSE: HAE ) ... & EVP-Business Development, will present at The Deutsche Bank 38 ... Boston, MA on May 29, 2013 at 1:30pm ... The public may access Mr. Lindop,s presentation live ... Haemonetics Haemonetics (NYSE: HAE ) is ...
(Date:5/23/2013)... PAUL, Minn. , May 23, 2013  MGC ... Corporation), a global medical technology company, today scheduled a ... second quarter of fiscal year 2013, ended April 30, ... on Thursday, May 30, 2013. The Company will report ... 2013 after the markets close on Thursday, May 30, ...
(Date:5/23/2013)... -- Hadasit Bio-Holdings Ltd. (TASE: HDST, OTC: HADSY), a ... intellectual property developed and owned by Hadassah University ... research center, today announced that its portfolio company, ... the Israeli Ministry of Industry and Commerce, Office ... development and advance clinical trials. Cell Cure,s development ...
Breaking Medicine Technology:MGC Diagnostics Corporation to Report Second Quarter Fiscal 2013 Financial Results on Thursday, May 30, 2013 2Hadasit Bio-Holdings Ltd. Portfolio Company - Cell Cure Neurosciences Ltd. Received Additional Government Support 2
(Date:5/24/2013)... May 2013, Paris, France: Routinely measuring fractional flow ... angiography for diagnosis of chest pain leads to ... four patients, according to results from a study ... routine pressure wire assessment influence management strategy at ... was designed to assess whether routine assessment of ...
(Date:5/24/2013)... Oregon Health & Science University highlights an ingenious method ... the highly evasive HIV virus that causes AIDS. The ... approach to develop its own HIV vaccine candidate, which ... This latest research finding will be published in the ... . , "A major challenge in developing an ...
(Date:5/24/2013)... 2013 CBT News.com recently announced the addition ... web-based retail automotive industry news organization with 12 years experience ... to join a group that’s so forward-thinking in their approach,” ... online video content is on the rise.” , Atlanta born ... and segued into advertising at Cycle News and Boating World. ...
(Date:5/24/2013)... American International College of Arts ... articulation agreement with Old Dominion University (ODU) ... Antigua. , The program will permit ODU ... a cell biology course, taught by AICASA’s faculty, for ... University of Antigua (AUA) College of Medicine , students ...
(Date:5/24/2013)... children who missed more than half of recommended well-child ... compared to children who attended most of their visits, ... American Journal of Managed Care . The study included ... , Children with chronic conditions like asthma and ... when they missed visits, according to the study. ...
Breaking Medicine News(10 mins):Health News:Diagnostic coronary angiography: Functional flow reserve changes decisions in 25 percent of cases 2Health News:OHSU research highlights promising strategy to help vaccines outsmart HIV 2Health News:AICASA Signs Articulation Agreement with Old Dominion University to Create Study Abroad Program 2Health News:Young children who miss well-child visits are more likely to be hospitalized 2Health News:Young children who miss well-child visits are more likely to be hospitalized 3
... Wash., Sept. 15 Edifecs, the leader in ... has,selected the Edifecs Healthcare Accelerator Suite to automate ... and batch modes,within the product and development areas ... Sunny Singh, Edifecs, CEO said: "In response ...
... Misys Resolve Dispute, DALLAS, Sept. 15 iMedica ... dispute with Misys,Healthcare Systems LLC ("Misys")., Under the ... iMedica,PRM 2008 practice management (PM) and electronic health record ... its customers. The,agreement also states that iMedica will provide ...
... grant from the National Cancer Institute to find out ... tailored education in the user,s preferred language increases the ... The funding will be used to refine custom-designed software, ... evaluate its clinical impact in primary care physician,s offices ...
... Li, associate professor of biological sciences at Virginia ... cellular innate immunity network and human chronic inflammatory ... diseases. The finding presents a viable cellular and ... serious human inflammatory diseases, according to Li. ...
... advice , , MONDAY, Sept. 15 (HealthDay News) -- A ... about how they can preserve their ability to have ... , "It,s overwhelming for cancer patients to have ... same time that they are struggling to come to ...
... 15 Optical Cable,Corporation (Nasdaq: OCCF ), announced ... 2008 results today, September 15, 2008. The third,quarter results ... 2008. In conjunction with its release, the Company will ... 10:00 a.m. Eastern Time., Individuals wishing to participate ...
Cached Medicine News:Health News:Unisys Selects Edifecs Healthcare Accelerator Suite(TM) for MMIS System 2Health News:iMedica Announces Agreement with Misys 2Health News:UC Davis doctors use multimedia to increase colorectal cancer screening among Hispanics 2Health News:Key protein molecule linked to diverse human chronic inflammatory diseases 2Health News:Web Site Helps Cancer Patients With Fertility Preservation 2Health News:Optical Cable Corporation Schedules Conference Call to Discuss Third Quarter 2008 Results 2Health News:Optical Cable Corporation Schedules Conference Call to Discuss Third Quarter 2008 Results 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: